In this regard, also Hu et al.13 measured increased levels of genes responsible for cellular defense against ROS (including GCLC, GSR, GST-pi and SOD1/2) following treatment of leukemia cells with Vorinostat. The gene discussed is GCLC; the disease is leukemia.